Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 1/20 | 0.60 |
| ▸ | ATM | Q13315 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | AHR | P35869 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 4/20 | 0.50 |
| ▸ | HTR2C | P28335 | 4/20 | 0.50 |
| ▸ | HTR6 | P50406 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MPO | P05164 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | HTR1D | P28221 | 1/20 | 0.50 |
| ▸ | HTR1B | P28222 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23704203 | 0.98 | GFER (0.58) | GFERATMCYP3A4GPR84MEN1 | |
| Iodide SCHEMBL2316312 | 0.98 | GFER (0.58) | GFERATMCYP3A4GPR84MEN1 | |
| SCHEMBL28110454 | 0.98 | GFER (0.58) | GFERATMCYP3A4GPR84MEN1 | |
| Bromide SCHEMBL28737265 | 0.98 | GFER (0.58) | GFERATMCYP3A4GPR84MEN1 | |
| Propane SCHEMBL28730352 | 0.91 | GFER (0.53) | GFERATMCYP3A4GPR84MEN1 | |
| SCHEMBL8079562 | 0.88 | GFER (0.50) | GFERATMCYP3A4GPR84MEN1 | |
| SCHEMBL28637564 | 0.82 | GFER (0.49) | GFERATMCYP3A4GPR84MEN1 | |
| SCHEMBL7300286 | 0.82 | ATM (0.50) | GFERATMCYP3A4GPR84MEN1 | |
| Trifluoroacetic Acid SCHEMBL30233736 | 0.82 | MAPK1 (0.57) | GFERATMGPR84MEN1MAPT | |
| SCHEMBL31397676 | 0.76 | GFER (1.00) | GFERATMCYP3A4MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5835 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122095084-A | Antigen-specific T cell receptors and chimeric antigen receptors and methods of use in modulation of immune signaling for cancer immunotherapy | — | 2026-05-26 | — | — | CN | claimed |
| US-20260137817-A1 | COMBINATION CANCER IMMUNOTHERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX | GALERA LABS LLC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4731758-A2 | ANTIGEN-SPECIFIC T CELL RECEPTORS AND CHIMERIC ANTIGEN RECEPTORS, AND METHODS OF USE IN IMMUNE SIGNALING MODULATION FOR CANCER IMMUNOTHERAPY | The Methodist Hospital (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4688823-A2 | BIFUNCTIONAL MOLECULES TARGETING LYMPH NODE PROGENITOR EXHAUSTED T CELLS AND METHODS OF USE | The Board of Trustees of the Leland Stanford Junior University (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4076482-B1 | COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, ENHANCING DRUG POTENCY AND TREATING CANCER | PERSEPHONE BIOSCIENCES INC (US) | 2025-11-26 | — | — | EP | claimed |
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| US-12415988-B2 | Enhanced differentiation of mesenchymal stem cells | ESCAPE THERAPEUTICS, INC. | 2025-09-16 | — | — | US | claimed |
| EP-3630807-B1 | PD-1 AND CTLA-4 DUAL INHIBITOR PEPTIDES | LEIDOS INC (US) | 2025-08-13 | — | — | EP | claimed |
| EP-4594314-A1 | PYRIDAZIN-3(2H)-ONE AND PYRIDIN-2(1H)-ONE PARP INHIBITOR COMPOUNDS | Azkarra Therapeutics, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| US-20250144151-A1 | INTERACTION OF FIBROBLASTS AND IMMUNE CELLS FOR ACTIVATION AND USES THEREOF | SPINALCYTE LLC (US) | 2025-05-08 | — | — | US | claimed |
| WO-1991001756-A1 | METHOD FOR CHEMICAL PROMOTION OF THE EFFECTS OF LOW CURRENT TRANSCRANIAL ELECTROSTIMULATION | SKOLNICK MALCOLM H (US) | 1991-02-21 | — | — | WO | claimed |
| EP-0224830-B1 | GRAM NEGATIVE BACTERURIA TEST | MILES INC. (US) | 1991-01-16 | — | — | EP | claimed |
| EP-0360077-A2 | Use of serotonin antagonists in the treatment of apoplexia cerebri | Troponwerke GmbH & Co. KG (DE) | 1990-03-28 | — | — | EP | claimed |
| US-4766110-A | INHIBITS ANGIOTENSIN CONVERTING ENZYME, HYPOTENSIVE AGENTS | RYAN JAMES W (US) | 1988-08-23 | — | — | US | claimed |
| US-4762781-A | COUPLED TO AMINE OR GUANIDINE GROUPS OF HAPTENS VIA REACTION WITH DIALDEHYDE, IMMUNOLOGY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1988-08-09 | — | — | US | claimed |
| US-4717658-A | URINARY TRACT INFECTIONS | MILES INC. (US) | 1988-01-05 | — | — | US | claimed |
| EP-0224830-A2 | Gram negative bacteruria test | MILES INC. (US) | 1987-06-10 | — | — | EP | claimed |
| EP-0073143-B1 | NOVEL COMPLEX AMIDO AND IMIDO DERIVATIVES OF CARBOXYALKYL PEPTIDES AND THIOETHERS AND ETHERS OF PEPTIDES | Ryan, James Walter (US) | 1985-11-21 | — | — | EP | claimed |
| EP-0149405-A2 | Antibodies capable of specifically recognizing haptenic groups, their preparation and application, and antigens for the preparation of these antibodies | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1985-07-24 | — | — | EP | claimed |
| EP-0073143-A2 | Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides | Ryan, James Walter (US) | 1983-03-02 | — | — | EP | claimed |